320 related articles for article (PubMed ID: 27639120)
1. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.
Scott JA; Braskie MN; Tosun D; Maillard P; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
Neurobiol Aging; 2016 Dec; 48():48-52. PubMed ID: 27639120
[TBL] [Abstract][Full Text] [Related]
2. Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly.
Scott JA; Braskie MN; Tosun D; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
Front Aging Neurosci; 2015; 7():221. PubMed ID: 26648866
[TBL] [Abstract][Full Text] [Related]
3. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
4. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
[TBL] [Abstract][Full Text] [Related]
5. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
[TBL] [Abstract][Full Text] [Related]
6. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
[TBL] [Abstract][Full Text] [Related]
8. Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-β in Cognitively Normal Individuals.
Wong FCC; Saffari SE; Yatawara C; Ng KP; Kandiah N;
J Alzheimers Dis; 2021; 84(1):91-101. PubMed ID: 34511497
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities are associated with subthreshold amyloid accumulation.
Moscoso A; Rey-Bretal D; Silva-Rodríguez J; Aldrey JM; Cortés J; Pías-Peleteiro J; Ruibal Á; Aguiar P;
Neuroimage; 2020 Sep; 218():116944. PubMed ID: 32445880
[TBL] [Abstract][Full Text] [Related]
10. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions.
Weaver NA; Doeven T; Barkhof F; Biesbroek JM; Groeneveld ON; Kuijf HJ; Prins ND; Scheltens P; Teunissen CE; van der Flier WM; Biessels GJ;
Neurobiol Aging; 2019 Dec; 84():225-234. PubMed ID: 31500909
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
Tubi MA; Feingold FW; Kothapalli D; Hare ET; King KS; Thompson PM; Braskie MN;
Neuroimage; 2020 Feb; 206():116327. PubMed ID: 31682983
[TBL] [Abstract][Full Text] [Related]
13. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
[TBL] [Abstract][Full Text] [Related]
14. Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.
Vipin A; Ng KK; Ji F; Shim HY; Lim JKW; Pasternak O; Zhou JH;
Hum Brain Mapp; 2019 May; 40(7):2065-2075. PubMed ID: 30604903
[TBL] [Abstract][Full Text] [Related]
15. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
[TBL] [Abstract][Full Text] [Related]
16. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensity topography in Alzheimer's disease and links to cognition.
Garnier-Crussard A; Bougacha S; Wirth M; Dautricourt S; Sherif S; Landeau B; Gonneaud J; De Flores R; de la Sayette V; Vivien D; Krolak-Salmon P; Chételat G
Alzheimers Dement; 2022 Mar; 18(3):422-433. PubMed ID: 34322985
[TBL] [Abstract][Full Text] [Related]
19. The association between white matter hyperintensities and amyloid and tau deposition.
Alban SL; Lynch KM; Ringman JM; Toga AW; Chui HC; Sepehrband F; Choupan J;
Neuroimage Clin; 2023; 38():103383. PubMed ID: 36965457
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.
Hawkins KA; Emadi N; Pearlson GD; Winkler AM; Taylor B; Dulipsingh L; King D; Pittman B; Blank K
Metab Brain Dis; 2017 Jun; 32(3):849-857. PubMed ID: 28255864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
